Insider Transactions
| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Mar 14, 2012 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,642 | -- | 10,207 |
| Mar 14, 2012 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,250 | -- | 6,250 |
| Mar 23, 2011 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,565 | -- | 3,565 |
| Mar 23, 2011 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,230 | -- | 17,643 |
| Feb 08, 2011 |
Director
Trans History: 9
|
Director | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 23, 2023 |
Chief Commercial Officer
Trans History: 23
|
Chief Commercial Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 92,243 | $1.38 | 946,304 |
| Aug 03, 2023 |
Chief Commercial Officer
Trans History: 23
|
Chief Commercial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 207,222 | -- | 1,038,547 |
| Aug 03, 2023 |
Chief Commercial Officer
Trans History: 23
|
Chief Commercial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 207,222 | -- | 207,222 |
| Jul 28, 2023 |
Chief Commercial Officer
Trans History: 23
|
Chief Commercial Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 37,207 | $1.64 | 831,325 |
| Aug 22, 2022 |
Chief Commercial Officer
Trans History: 23
|
Chief Commercial Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 64,872 | $3.08 | 868,532 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.